Matthew D. Linnik
Geen lopende functies
Profiel
Matthew D.
Linnik joined La Jolla Pharmaceutical Co. in 1998 as Director of Research and Development and was appointed Vice President of Research in February 1999, Executive Vice President of Research in June 1999, Chief Scientific Officer and Executive Vice President of Research in 2002 and Assistant Secretary in 1999.
Previously, he was Senior Pharmacologist, Scientist, Research Scientist and Project Leader of Hoechst Marion Roussel from 1989 to 1998, Adjunct Associate Professor of Neurosurgery at the University of Cincinnati School of Medicine from 1996 to 1998 and Postdoctoral Fellow and Instructor in the Departments of Neurology and Neurosurgery at Massachusetts General Hospital and the Harvard Medical School from 1986 to 1988.
Dr. Linnik received a BA degree in Physiology from Southern Illinois University and a PhD in Physiology and Pharmacology from the Southern Illinois University School of Medicine.
Eerdere bekende functies van Matthew D. Linnik
Bedrijven | Functie | Einde |
---|---|---|
LA JOLLA PHARMACEUTICAL COMPANY | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Matthew D. Linnik
Southern Illinois University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |